Literature DB >> 25844166

Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults.

Lee E Morris1, Roberto Posada1, Carole J Hickman2, Donald R Latner2, Tricia A Singh3, Alyssa Rautenberg3, Jennifer Jao4, William J Bellini2, Rhoda Sperling3.   

Abstract

Among our cohort of adolescents and young adults with perinatally acquired human immunodeficiency virus, few (17.6%) had measles protective antibodies by plaque reduction neutralization (PRN). Agreement was demonstrated between the commercial enzyme immunoassay and the PRN assay (K = 0.59 [95% confidence interval: 0.23-0.95]). Further studies are needed to understand the determinants of immunity in this population.
© The Author 2013. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; adolescents; measles immunity; perinatally acquired HIV infection.

Mesh：

Substances：

Year:  2013        PMID： 25844166      PMCID： PMC4381743          DOI： 10.1093/jpids/pit054

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  13 in total

1.  Measles antibody: reevaluation of protective titers.

Authors:  R T Chen; L E Markowitz; P Albrecht; J A Stewart; L M Mofenson; S R Preblud; W A Orenstein
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

Review 2.  Do children infected with HIV receiving HAART need to be revaccinated?

Authors:  Catherine G Sutcliffe; William J Moss
Journal:  Lancet Infect Dis       Date:  2010-09       Impact factor: 25.071

Review 3.  Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity.

Authors:  Pippa Scott; William J Moss; Zunera Gilani; Nicola Low
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

4.  Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.

Authors:  Sulachni Chandwani; Judy Beeler; Hong Li; Susette Audet; Betsy Smith; John Moye; David Nalin; Keith Krasinski
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

5.  Immunologic basis for revaccination of HIV-infected children receiving HAART.

Authors:  Kaitlin Rainwater-Lovett; William J Moss
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

6.  Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.

Authors:  Vincent Bekker; Henriëtte Scherpbier; Dasja Pajkrt; Suzanne Jurriaans; Hans Zaaijer; Taco W Kuijpers
Journal:  Pediatrics       Date:  2006-07-17       Impact factor: 7.124

7.  Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy.

Authors:  Ann J Melvin; Kathleen M Mohan
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

8.  Role of virus strain in conventional and enhanced measles plaque neutralization test.

Authors:  P Albrecht; K Herrmann; G R Burns
Journal:  J Virol Methods       Date:  1981-12       Impact factor: 2.014

9.  Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.

Authors:  S Ratnam; V Gadag; R West; J Burris; E Oates; F Stead; N Bouilianne
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

10.  Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.

Authors:  Carey Farquhar; Dalton Wamalwa; Sara Selig; Grace John-Stewart; Jennifer Mabuka; Maxwel Majiwa; William Sutton; Nancy Haigwood; Grace Wariua; Barbara Lohman-Payne
Journal:  Pediatr Infect Dis J       Date:  2009-04       Impact factor: 2.129
View more
  2 in total

1.  Measles and Rubella Seroprevalence Among HIV-infected and Uninfected Zambian Youth.

Authors:  Catherine G Sutcliffe; Kelly Searle; Hellen K Matakala; Michelle P Greenman; Kaitlin Rainwater-Lovett; Philip E Thuma; William J Moss
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

2.  Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis.

Authors:  Eleonora A M L Mutsaerts; Marta C Nunes; Martijn N van Rijswijk; Kerstin Klipstein-Grobusch; Diederick E Grobbee; Shabir A Madhi
Journal:  EClinicalMedicine       Date:  2018-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.